Shire announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse (lisdexamfetamine dimesylate) compared to Concerta (methylphenidate HCl) in patients with Attention Deficit ...

For 2011, Vyvanse turned in $805 million in sales. Concerta brought in $1.4 billion in 2010, its last full year without generic competiton. Besides looking for an edge in ADHD, Shire is studying ...

Shire has unveiled plans for two head-to-head studies comparing its attention-deficit hyperactivity disorder drug Vyvanse with Johnson & Johnson's rival product Concerta. Shire has unveiled plans for ...

Prospectively designed head-to-head clinical trials provide important information to physicians, patients, caregivers and payers to make informed choices. The two Phase 4 clinical trials are designed ...

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies of Vyvanse ® (lisdexamfetamine dimesylate) compared with Concerta (methylphenidate HCl) ...

As kids start heading back to school--and getting back on their ADHD meds--one analyst expected Shire's ($SHPG) Vyvanse to steal market share from Johnson & Johnson's ...

Shire has amassed a 560-person sales force to launch its new ADHD drug Vyvanse. The sales team began targeting specialist physicians treating ADHD including pediatricians, pediatric neurologists and ...

Shire has amassed a 560-person sales force in advance of its Monday launch of new attention deficit hyperactivity drug Vyvanse. Shire CEO Matthew Emmens said he is hopeful the drug will be able to ...

The national ADHD medicine shortage, which has impacted access to generic versions of Adderall, Vyvanse, and Concerta, was first announced back in October 2022. Now, 16 months later, patients are ...

Imagine you or your child has attention deficit hyperactivity disorder (ADHD), and after several weeks, or even months, you’ve found a dose of medication you’re happy with. The problems you previously ...

Treating attention deficit hyperactivity disorder (ADHD) with stimulant medication may reduce smoking risk, especially when medication is taken consistently, according to an analysis. ADHD is a common ...